Five-Year Follow-Up of Lung Cancer Patients Treated with Nivolumab

Five-Year Follow-Up of Lung Cancer Patients Treated with Nivolumab

User Photo
aacr2017

3 years
758 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center gives an overview of her presentation which discussed a five-year follow-up of Lung Cancer patients, who were treated with Nivolumab. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Up Next Autoplay